文献速递疼痛医学

氯胺酮输注对医疗资源利用和慢性疼痛的影响:基于真实世界数据的比较效果研究

Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-03

本研究利用真实世界数据,比较氯胺酮输注与常规治疗对慢性疼痛患者疼痛相关医疗资源利用的影响。研究纳入118例接受静脉氯胺酮输注的慢性疼痛患者,并通过倾向评分匹配创建118例对照队列。结果显示,氯胺酮组治疗后6个月非预期医疗资源利用较治疗前6个月下降,而对照组同期上升;与对照组相比,氯胺酮治疗与疼痛相关就诊减少45%相关(p<0.001)。

要点

  • 静脉氯胺酮输注可减少慢性疼痛患者6个月内的非预期疼痛相关医疗资源利用。
  • 与常规治疗相比,氯胺酮治疗与疼痛相关就诊减少45%相关(p<0.001)。
  • 真实世界数据可用于补充临床试验,评估氯胺酮门诊输注效果。

核心结论

  • 静脉氯胺酮在减少慢性疼痛患者6个月以上非预期疼痛相关医疗资源利用方面优于常规治疗。

研究设计与样本

  • 比较效果研究,利用真实世界数据,纳入118例接受静脉氯胺酮输注的慢性疼痛患者,并通过倾向评分匹配创建118例对照队列。

主要发现

  • 氯胺酮组治疗后6个月非预期医疗资源利用较治疗前6个月下降,对照组同期上升。
  • 氯胺酮治疗与疼痛相关就诊减少45%相关(p<0.001)。

临床怎么用

  • 对于慢性疼痛患者,可考虑静脉氯胺酮输注以减少疼痛相关急诊、紧急护理和住院等医疗资源利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies provide conflicting evidence for ketamine's effectiveness in treating chronic pain, in the context of limited real-world evidence to augment clinical trial findings. We conducted a comparative effectiveness study with real-world data to assess the impact of ketamine infusions on pain-related healthcare utilization, to bridge the gap between clinical trials and real-life care. METHODS: We identified 118 subjects who received intravenous (IV) ketamine infusions for chronic pain between 2018 and 2022. Using the University of Pittsburgh's patient outcomes repository for treatment registry, we created a propensity score-matched control cohort of 118 subjects. Real-world data from the University of Pittsburgh Medical Center healthcare network was analyzed to compare unexpected pain-related healthcare utilization, including emergency room visits, urgent care visits, and hospital admissions. Utilization was assessed 6 months before and after ketamine infusion and compared with the matched control cohort. RESULTS: The ketamine cohort demonstrated a decrease in unexpected healthcare utilization 6 months after treatment compared with 6 months prior, while the control cohort showed an increase during the same period. Ketamine treatment was associated with a 45% reduction in pain-related visits compared with the control cohort (p<0.001). CONCLUSIONS: IV ketamine was more effective than conventional therapy in reducing unexpected pain-related healthcare utilization for over 6 months in patients with chronic pain. Our study highlights the value of using real-world data and comparative effectiveness research to supplement clinical trials and enhance our understanding of the possible effects of outpatient ketamine infusion therapy.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Wang S, O'Connell B, DeSensi RS, et al. Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data. Reg Anesth Pain Med. 2026. PMID: 41775497. doi:10.1136/rapm-2025-106975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。